Loading...
Based on the data provided, Baxter International Inc (BAX) is not a strong buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock has mixed financials, weak technical indicators, and a lack of strong positive catalysts. It is recommended to hold off on purchasing this stock until there are clearer signs of improvement in financial performance and sentiment.
The technical indicators for BAX are weak. The MACD is negative and expanding, indicating bearish momentum. The RSI is neutral at 40.997, showing no clear signal. Moving averages are converging, which suggests indecision in the market. Key support levels are at 19.113, with resistance at 21.791. Overall, the stock is in a bearish trend.

The company's Q4 2025 revenue increased by 8.03% YoY to $2.97 billion, showing growth in sales. Analysts have noted growth across all segments despite some challenges.
Gross margin dropped by 45.16% YoY, indicating declining profitability. Analysts have lowered price targets, citing margin pressures, underwhelming 2026 guidance, and limited near-term visibility. Technical indicators and trading sentiment are weak, with no recent positive news or congress trading data.
In Q4 2025, Baxter's revenue increased by 8.03% YoY to $2.97 billion. However, net income was -$1.128 billion, up 120.31% YoY but still negative. EPS was -2.2, also up 120% YoY but negative. Gross margin dropped significantly to 20.24%, down 45.16% YoY, reflecting profitability challenges.
Analysts have a neutral to cautious outlook on BAX. Multiple firms have lowered their price targets, with the current range between $17 and $25. Analysts cite margin pressures, underwhelming 2026 guidance, and mixed Q4 results as reasons for their cautious stance. While some see potential for long-term recovery, the near-term outlook remains uncertain.